electronic health records Archives
Oct. 20, 2023—Vanderbilt's Bryan Shepherd, PhDhas received a MERIT Award, or Method to Extend Research in Time Award, from the National Institute of Allergy and Infectious Diseases.
Aug. 15, 2023—Vanderbilt researchers have developed a computer algorithm that scans electronic health records, or EHRs, to identify patients who meet criteria for lung cancer screening.
Jun. 22, 2023—Genetic mosaicism — when the body’s cells do not all have the same genetic makeup — could generate variants previously thought to be spontaneous in genetic disease, and detecting parental mosaicism could clarify recurrence risk for future children.
Mar. 23, 2023—A Vanderbilt study found that automated targeted reminders for clinicians helped increase prescribing of high intensity statins for patients with various atherosclerotic cardiovascular disease diagnoses, including coronary or peripheral artery disease and ischemic stroke.
Mar. 22, 2023—A survey sent to more than 43,000 patients living in several states around the country finds that 96% of patients who use patient web portals prefer immediate online access to their clinical test results.
Oct. 13, 2022—A team at Vanderbilt University Medical Center will explore computational solutions to help address the problem of missed or delayed diagnosis for patients with rare genetic diseases.
Sep. 22, 2022—Vanderbilt policy experts discuss how the recent U.S. Supreme Court decision overturning Roe v. Wade and newly enacted state laws limiting or banning abortion can be expected to bring new scrutiny to the privacy vulnerabilities of electronic health records.
Aug. 11, 2022—Vanderbilt is collaborating with several other medical systems to implement a predictive tool that uses machine learning to extract patient behaviors documented by nurses in electronic health records and transform them into observable data.
Jun. 29, 2022— by Jill Clendening Patients whose race is recorded as Black in their electronic health record (EHR) are more likely to have azathioprine, an immunosuppressant medication, discontinued or its dose reduced because their laboratory results show a low white blood cell count. This lab finding was not a factor of race, but instead was linked...